These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9408226)
1. Effects of varying marijuana potency on deposition of tar and delta9-THC in the lung during smoking. Matthias P; Tashkin DP; Marques-Magallanes JA; Wilkins JN; Simmons MS Pharmacol Biochem Behav; 1997 Dec; 58(4):1145-50. PubMed ID: 9408226 [TBL] [Abstract][Full Text] [Related]
2. Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC. Tashkin DP; Gliederer F; Rose J; Change P; Hui KK; Yu JL; Wu TC Pharmacol Biochem Behav; 1991 Nov; 40(3):651-6. PubMed ID: 1666923 [TBL] [Abstract][Full Text] [Related]
3. Tar, CO and delta 9THC delivery from the 1st and 2nd halves of a marijuana cigarette. Tashkin DP; Gliederer F; Rose J; Chang P; Hui KK; Yu JL; Wu TC Pharmacol Biochem Behav; 1991 Nov; 40(3):657-61. PubMed ID: 1666924 [TBL] [Abstract][Full Text] [Related]
4. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary hazards of smoking marijuana as compared with tobacco. Wu TC; Tashkin DP; Djahed B; Rose JE N Engl J Med; 1988 Feb; 318(6):347-51. PubMed ID: 3340105 [TBL] [Abstract][Full Text] [Related]
6. Chronic marijuana smoke exposure in the rhesus monkey. I. Plasma cannabinoid and blood carboxyhemoglobin concentrations and clinical chemistry parameters. Slikker W; Paule MG; Ali SF; Scallet AC; Bailey JR Fundam Appl Toxicol; 1991 Aug; 17(2):321-34. PubMed ID: 1684942 [TBL] [Abstract][Full Text] [Related]
7. Are choice and self-administration of marijuana related to delta 9-THC content? Kelly TH; Foltin RW; Emurian CS; Fischman MW Exp Clin Psychopharmacol; 1997 Feb; 5(1):74-82. PubMed ID: 9234042 [TBL] [Abstract][Full Text] [Related]
8. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid. Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597 [TBL] [Abstract][Full Text] [Related]
10. Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. Sarafian TA; Magallanes JA; Shau H; Tashkin D; Roth MD Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1286-93. PubMed ID: 10340948 [TBL] [Abstract][Full Text] [Related]
11. Delta-9-tetrahydrocannabinol content and human marijuana self-administration. Chait LD Psychopharmacology (Berl); 1989; 98(1):51-5. PubMed ID: 2543018 [TBL] [Abstract][Full Text] [Related]
12. Preference for high- versus low-potency marijuana. Chait LD; Burke KA Pharmacol Biochem Behav; 1994 Nov; 49(3):643-7. PubMed ID: 7862719 [TBL] [Abstract][Full Text] [Related]
13. The tar reduction study: randomised trial of the effect of cigarette tar yield reduction on compensatory smoking. Frost C; Fullerton FM; Stephen AM; Stone R; Nicolaides-Bouman A; Densem J; Wald NJ; Semmence A Thorax; 1995 Oct; 50(10):1038-43. PubMed ID: 7491550 [TBL] [Abstract][Full Text] [Related]
14. Relationship between cigarette yields, puffing patterns, and smoke intake: evidence for tar compensation? Sutton SR; Russell MA; Iyer R; Feyerabend C; Saloojee Y Br Med J (Clin Res Ed); 1982 Aug 28-Sep 4; 285(6342):600-3. PubMed ID: 6819031 [TBL] [Abstract][Full Text] [Related]
15. Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance. Heishman SJ; Stitzer ML; Yingling JE Pharmacol Biochem Behav; 1989 Sep; 34(1):173-9. PubMed ID: 2560548 [TBL] [Abstract][Full Text] [Related]
16. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389 [TBL] [Abstract][Full Text] [Related]
17. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study. ElSohly MA; deWit H; Wachtel SR; Feng S; Murphy TP J Anal Toxicol; 2001 Oct; 25(7):565-71. PubMed ID: 11599601 [TBL] [Abstract][Full Text] [Related]
18. Cannabis smoke condensate I: the effect of different preparation methods on tetrahydrocannabinol levels. Van der Kooy F; Pomahacova B; Verpoorte R Inhal Toxicol; 2008 Jul; 20(9):801-4. PubMed ID: 18645719 [TBL] [Abstract][Full Text] [Related]
19. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444 [TBL] [Abstract][Full Text] [Related]
20. Salivary THC following cannabis smoking correlates with subjective intoxication and heart rate. Menkes DB; Howard RC; Spears GF; Cairns ER Psychopharmacology (Berl); 1991; 103(2):277-9. PubMed ID: 1851311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]